News
Rio Tinto, Hancock to Jointly Invest $1.6 Billion in Hope Downs 2 Project The world's second-largest miner by market value said the project will include two new pits capable of producing a combined 31 ...
Stocks rallied Tuesday after U.S. President Donald Trump announced a ceasefire in the Israel-Iran conflict, although the ...
The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its ...
Stocks rally and oil tumbles as Wall Street hopes for a limited retaliation after US strikes on Iran
The calming in the oil market came as several analysts said Iran would likely refrain from closing the waterway. Iran itself ...
2h
Stocktwits on MSNHims & Hers Stock Rebounds After-Hours After Novo Nordisk Split Triggers Record Plunge — Retail Traders Stay LoyalHims & Hers Health Inc. (HIMS) rebounded 4.38% in after-hours trading Monday, partially clawing back losses after the stock ...
The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations ...
Novo Nordisk said Monday it will end its collaboration with Hims & Hers that offered the weight loss medication Wegovy for patients who have a prescription for the medication but no insurance coverage ...
Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...
Trump’s tariffs and the trade war continue to affect global markets as the Israel-Iran conflict unfolds. Follow along for live updates on the Dow, S&P 500 and Nasdaq.
Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the federal securities laws.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results